They Built the First Real Alzheimerās Drug.
Biogen (BIIB) developed the first real Alzheimerās drug, a breakthrough the industry had been chasing for decades. When it got approved, the stock ran hard. Then the rollout took longer than the early excitement assumed, the share price cooled off, and BIIB spent a long stretch grinding sideways before it found its footing again. It…
